Oligoclonal T cells transiently expand and express TIM3 and LAG3 following CD19 CAR t cell therapy.

被引：0

作者：

Petersen, Christopher Thomas

Jagirdar, Neera

Waller, Edmund K.

机构：

[1] Emory Univ, Atlanta, GA USA

[2] Emory Clin, Atlanta, GA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.e19017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19017

引用

页数：6

共 50 条

[41] Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy [J].

Juluri, Krishna R. ;

Wu, Qian Vicky ;

Voutsinas, Jenna ;

Hou, Jue ;

Hirayama, Alexandre, V ;

Mullane, Erin ;

Miles, Nancy ;

Maloney, David G. ;

Turtle, Cameron J. ;

Bar, Merav ;

Gauthier, Jordan .

BLOOD ADVANCES, 2022, 6 (07) :2055-2068

[42] Novel CD19t T-Antigen Presenting Cells Designed to Re-Activate and Expand CD19 CAR T Cells In Vivo: Early Demonstration of Feasibility and Safety [J].

Annesley, Colleen ;

Gardner, Rebecca ;

Finney, Olivia ;

Summers, Corinne ;

Lamble, Adam J. ;

Rivers, Julie ;

Johnson, Adam ;

Spratt, Karen ;

Mgebroff, Stephanie ;

Brown, Christopher ;

Lindgren, Catherine ;

Park, Julie R. ;

Jensen, Michael C. .

BLOOD, 2018, 132

[43] Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell [J].

Nie, Esther H. ;

Su, Yi-Jiun ;

Baird, John H. ;

Agarwal, Neha ;

Bharadwaj, Sushma ;

Weng, Wen-Kai ;

Smith, Melody ;

Dahiya, Saurabh ;

Han, May H. ;

Dunn, Jeffrey E. ;

Kipp, Lucas B. ;

Miklos, David B. ;

Scott, Brian J. ;

Frank, Matthew J. .

BLOOD ADVANCES, 2024, 8 (06) :1474-1486

[44] Cytomegalovirus reactivation after CD19 CAR T-cell therapy is clinically significant [J].

Chen, George ;

Herr, Megan ;

Nowak, Jan ;

Ho, Christine ;

Almyroudis, Nikolaos ;

Attwood, Kristopher ;

Bonnewell, John ;

Walsh, Marissa ;

Segal, Brahm ;

Ross, Maureen ;

McCarthy, Philip ;

Hahn, Theresa .

HAEMATOLOGICA, 2023, 108 (02) :615-620

[45] REFRACTORY PTLD WITH DLBCL PHENOTYPE TREATED WITH CD19 CAR T-CELL THERAPY [J].

Whitman, Abbie ;

Damodharan, Sudarshawn ;

Capitini, Christian .

PEDIATRIC BLOOD & CANCER, 2023, 70 :S73-S74

[46] CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases? [J].

Rangel-Pelaez, Carlos ;

Martinez-Gutierrez, Laura ;

Tristan-Manzano, Maria ;

Callejas, Jose Luis ;

Ortego-Centeno, Norberto ;

Martin, Francisco ;

Martin, Javier .

FRONTIERS IN IMMUNOLOGY, 2024, 15

[47] The Lymphoma Tumor Microenvironment Influences Toxicity after CD19 CAR T Cell Therapy [J].

Jain, Michael D. ;

Faramand, Rawan ;

Staedtke, Verena ;

Bai, Renyuan ;

Lee, Sae Bom ;

Kotani, Hiroshi ;

Reid, Kayla ;

Spitler, Kristen ;

Chavez, Julio ;

Shah, Bijal ;

Bachmeier, Christina A. ;

Dam, Marian ;

Brandjes, Brigett ;

Gonzalez, Ricardo J. ;

Mullinax, John E. ;

Wang, Xuefeng ;

Hussaini, Mohammad ;

Locke, Frederick L. ;

Davila, Marco L. .

BLOOD, 2019, 134

[48] Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy [J].

Tang, Kevin ;

Khwaja, Raamis ;

Feng, Lei ;

Strati, Paolo ;

Steiner, Raphael E. ;

Nair, Ranjit ;

Flowers, Christopher R. ;

Saini, Neeraj ;

Ramdial, Jeremy L. ;

Srour, Samer A. ;

Champlin, Richard E. ;

Rondon, Gabriela ;

Torres, Janet ;

Kebriaei, Partow ;

Nastoupil, Loretta J. ;

Mistry, Haleigh ;

Shpall, Elizabeth J. ;

Nieto, Yago ;

Westin, Jason ;

Neelapu, Sattva S. ;

Ahmed, Sairah .

BLOOD, 2022, 140 :4684-4685

[49] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy [J].

Lihong An ;

Yuehui Lin ;

Biping Deng ;

Zhichao Yin ;

Defeng Zhao ;

Zhuojun Ling ;

Tong Wu ;

Yongqiang Zhao ;

Alex H. Chang ;

Chunrong Tong ;

Shuangyou Liu .

BMC Cancer, 22

[50] Evaluating hypogammaglobulinemia after CD19 CAR T-cell therapy- Reply [J].

Sutherland, Natalia M. ;

Barmettler, Sara .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (05) :1688-1689

← 1 2 3 4 5 →